Summaries are drawn from public sources and link to them. HSH does not give a risk rating: read the summary and sources and reach your own view. Unproven allegations are labelled as such. Suppliers can submit a response, which is shown alongside.
Latest full-year results from official filings.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Credible news about incidents, disputes, legal action or restructuring in the last 24 months.
No adverse media involving Aidoc found in HSH's search of the last 24 months.
Data breaches, cyber incidents, regulator action and assurance status.
No data breaches, cyber incidents or regulator action involving Aidoc found in HSH's search of the last 24 months. NHS DSPT status not yet checked.
Recalls, safety notices, regulator action and clinical safety concerns.
Jan 2026: Aidoc received FDA clearance for its foundation-model AI triage platform. No recalls, warning letters or safety notices involving Aidoc found in HSH's search of the last 24 months.
Contract delivery, go-lives, terminations and disputes.
No notable NHS contracts, troubled implementations, disputes or terminations involving Aidoc found in HSH's search of the last 24 months.